Liver transplantation in hepatocellular carcinoma

Transplant International

Volumn 18, Issue 3, 2005, Pages 278-282

  Fuster, Josep ^a   Charco, Ramón ^a   Llovet, Josep M ^a   Bruix, Jordi ^a   García Valdecasas, Juan Carlos ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Living donor liver transplant

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CHEMOEMBOLIZATION; DISEASE COURSE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME; DONOR; LIVER TUMOR;

CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; TISSUE DONORS;

EID: 20844439050     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.00046.x     Document Type: Review

References (50)

1. Bruix J, Sherman M, Llovet JM, et al. for the EASL Panel of experts on HCC. Clinical management of hepatocellular carcinoma. J Hepatol 2001; 35: 421.
2. Llovet JM, Fuster J, Bruix J and BCLC group. Prognosis of hepatocellular carcinoma. Hepatogastroenterology 2002; 49: 7.
3. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in HCC. Hepatology 2002; 35: 519.
4. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62.
5. Iwatsuki S, Klintmalm GBG, Starzl T. Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 1982; 6: 81.
6. Bismuth H, Castaign D, Ericzon BFT, et al. Hepatic transplantation in Europe. First report of the European Liver Transplant Registry. Lancet 1987; 2: 674.
7. O'Grady JG, Polson RJ, Rolles K, et al. Results in 93 consecutive patients. Liver transplantation for malignant disease. Ann Surg 1988; 207: 373.
8. Ringe B, Wittekind C, Bechtein WO, et al. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989; 209: 88.
9. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726.
10. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl T. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202: 401.
11. Iwatsuki S, Starzl TE, Todo S, et al. Experience in 1000 liver transplants under cyclosporine-steroid therapy: a survival report. Trans Proc 1988; 20: 498.
12. Gores G. Liver transplantation for malignant disease. Gastroenterol Clin North Am 1993; 22: 285.
13. Mion F, Grozel L, Boillot O, et al. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996; 111: 1587.
14. Suárez Y, França A, Llovet JM, Fuster J, Bruix A. The current status of liver transplantation for primary hepatic malignancy. Clin Liver Dis 2000; 4(3): 591.
15. Yuki K, Hirohhasi S, Sakamoto M, et al. Growth and spread of hepatocellular carcinoma: a review of 240 consecutive autopsy cases. Cancer 1990; 66: 2174.
16. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 2: 145.
17. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients. A cohort study comparing surgical resection versus percutaneous ethanol injection. Hepatology 1993; 18: 1121.
18. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinoma in patients with cirrhosis. New Engl J Med 1996; 334: 693.
19. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the TNM classification does not have prognostic power. Hepatology 1998; 27: 1572.
20. Wall WJ. Liver transplantation for hepatic and biliary malignancy. Sem Liver Dis 2000; 20: 425.
21. Llovet JM, Fuster J, Bruix J and the Barcelona Liver Cancer Study group. Intention to treat analysis of radical treatment for early hepatocellular carcinoma: resection vs. transplantation. Hepatology 1999; 30: 1434.
22. Fuster J, García-Valdecasas JC, Grande L, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996; 223: 297.
23. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Sem Liver Dis 1999; 19: 329.
24. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018.
25. Franco D, Cappussotti L, Smadja C, et al. Resection of hepatocellular carcinoma: results in 72 European patients with cirrhosis. Gastroenterology 1990; 98: 773.
26. Belghiti J, Panis Y, Farges O, Benhamou JP, Fékété F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114.
27. Ringe B, Pichlmayr R, Wittekind C, et al. Surgical treatment for hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270.
28. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488.
29. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618.
30. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993; 18: 226.
31. Figueras J, Jaurrieta E, Vails C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485.
32. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257.
33. Pruett TL. The allocation of livers for transplantation: a problem of titanic consideration. Hepatology 2002; 35: 960.
34. Vargas HE, Laskus T, Wang LF, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts (see comments). Gastroenterology 1999; 117: 149.
35. Schmidt HH, Nashan B, Propsting MJ, et al. Familial amyloidotic polyneuropathy: domino liver transplantation. J Hepatol 1999; 30: 293.
36. Malago M, Hertl M, Testa G, Rogiers X, Broelsch CE. Split liver transplantation: future use of scarce donor organs. World J Surg 2002; 26: 275.
37. Marcos A. Right lobe living donor liver transplantation: a review. Liver Transplant 2000; 6: 3.
38. Sarasin F, Majno P, Llovet JM, Mentha J, Bruix J, Hadengue A. Liver donor liver transplantation for early hepatocellular carcinoma: a cost-effectiveness perspective. Hepatology 2001; 33: 1073.
39. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 2002; 235: 533.
40. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
41. Stone MJ, Klintmalm GBT, Potter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology 1993; 104: 196.
42. Carr BI, Selby R, Madariaga J, et al. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Trans Proc 1993; 25: 1128.
43. Cherqui D, Piedbois P, Pierga JY, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. Cancer 1994; 73: 2721.
44. Olthoff KM, Rosove MH, Shackelton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221: 734.
45. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688.
46. Llovet JM, Real I, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734.
47. Vilana R, Bruix J, Bru C, Ayuso C, Solé M, Rodés J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992; 16: 353.
48. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101.
49. Llovet JM, Mas X, Aponte J, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002; 50: 123.
50. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609.